DK0904067T3 - Transdermalt indgivet dextromethorpan som hostestillende middel - Google Patents

Transdermalt indgivet dextromethorpan som hostestillende middel

Info

Publication number: DK0904067T3
Authority: DK; Denmark
Prior art keywords: dextromethorpane; transdermally administered; cough suppressant; morphanin; prodrugs
Prior art date: 1996-04-23

Application number

DK97915801T

Other languages

Danish (da)

English (en)

Inventor

Ulla Hoeck

Bo Kreilgard

Helle Kristensen

Original Assignee

Pfizer Health Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-23

Filing date

1997-03-21

Publication date

2005-03-14

1997-03-21 Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab

2005-03-14 Application granted granted Critical

2005-03-14 Publication of DK0904067T3 publication Critical patent/DK0904067T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK97915801T 1996-04-23 1997-03-21 Transdermalt indgivet dextromethorpan som hostestillende middel DK0904067T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9601528A SE9601528D0 (sv)	1996-04-23	1996-04-23	Transdermally administered dextromethorphan as antitissue agent
PCT/SE1997/000484 WO1997039742A1 (en)	1996-04-23	1997-03-21	Transdermally administered dextromethorphan as antitussive agent

Publications (1)

Publication Number	Publication Date
DK0904067T3 true DK0904067T3 (da)	2005-03-14

Family

ID=20402295

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97915801T DK0904067T3 (da)	1996-04-23	1997-03-21	Transdermalt indgivet dextromethorpan som hostestillende middel

Country Status (14)

Country	Link
US (1)	US6335030B1 (de)
EP (1)	EP0904067B1 (de)
JP (1)	JP2000509037A (de)
AT (1)	ATE284206T1 (de)
AU (1)	AU714942B2 (de)
CA (1)	CA2251966C (de)
DE (1)	DE69731882T2 (de)
DK (1)	DK0904067T3 (de)
ES (1)	ES2234012T3 (de)
NZ (1)	NZ332215A (de)
PT (1)	PT904067E (de)
SE (1)	SE9601528D0 (de)
WO (1)	WO1997039742A1 (de)
ZA (1)	ZA973444B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6846495B2 (en) *	1999-01-11	2005-01-25	The Procter & Gamble Company	Compositions having improved delivery of actives
DE19901085C2 (de) *	1999-01-14	2003-12-18	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
GB9920167D0 (en) *	1999-08-25	1999-10-27	Avery Dennison Corp	Pressure sensitive adhesive compositions
US7138133B2 (en)	2001-10-10	2006-11-21	The Procter & Gamble Company	Orally administered liquid compositions
US7662404B2 (en) *	2002-10-31	2010-02-16	Transpharma Medical Ltd.	Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
IL152574A (en) *	2002-10-31	2009-09-22	Transpharma Medical Ltd	A system for passing through the skin of dry items or dried medicines
US8133505B2 (en) *	2002-10-31	2012-03-13	Transpharma Medical Ltd.	Transdermal delivery system for dried particulate or lyophilized medications
US7383084B2 (en) *	2002-10-31	2008-06-03	Transpharma Medical Ltd.	Transdermal delivery system for dried particulate or lyophilized medications
US8502681B2 (en) *	2005-06-20	2013-08-06	Biovigil, Llc	Hand cleanliness
JP5015620B2 (ja) *	2007-01-30	2012-08-29	株式会社クラレ	皮膚外用剤
US20100160368A1 (en)	2008-08-18	2010-06-24	Gregory Jefferson J	Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
MX346455B (es)	2008-12-19	2017-03-21	Medicis Pharmaceutical Corp	Formulaciones de imiquimod de baja concentracion de dosis y regimenes de dosis de corta duracion para tratar queratosis actinica.
EP2453747B1 (de)	2009-07-13	2017-08-30	Medicis Pharmaceutical Corporation	Imiquimod-formulierungen mit geringerer dosisstärke und kurze dosierpläne zur behandlung von warzen im genital- und perianalbereich
US8461102B2 (en) *	2010-03-02	2013-06-11	George E. Royster, JR.	Methods and compositions for treating and preventing symptoms of hormonal variations
US10493049B2 (en)	2016-02-10	2019-12-03	Niracle LLC	Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
TWI795446B (zh) *	2017-10-04	2023-03-11	美商神經治療股份有限公司	右旋美索芬(dextromethorphan)經皮輸送裝置
IL296624A (en) *	2020-03-30	2022-11-01	Shinkei Therapeutics Inc	Transdermal transfer of dextromethorphan
US11844753B2 (en)	2021-11-08	2023-12-19	Weiyong Li	Transdermal drug delivery system for delivering a drug to a patient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3275510A (en) *		1966-09-27		Topical antitussive preparations
US2676177A (en)	1949-11-09	1954-04-20	Hoffmann La Roche	Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof
US4557934A (en)	1983-06-21	1985-12-10	The Procter & Gamble Company	Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4645502A (en) *	1985-05-03	1987-02-24	Alza Corporation	Transdermal delivery of highly ionized fat insoluble drugs
JPS6351327A (ja) *	1986-08-22	1988-03-04	Sato Seiyaku Kk	液状組成物
US4783450A (en)	1987-04-13	1988-11-08	Warner-Lambert Company	Use of commercial lecithin as skin penetration enhancer
US4888354A (en)	1987-12-21	1989-12-19	Theratech, Inc.	Skin penetration enhancement using free base and acid addition salt combinations of active agents
US4915950A (en)	1988-02-12	1990-04-10	Cygnus Research Corporation	Printed transdermal drug delivery device
US5164406A (en)	1988-06-02	1992-11-17	Bristol-Myers Squibb Co.	Method for enhancing transdermal penetration and compositions useful therein
EP0351897A3 (de)	1988-06-17	1990-03-21	The Procter & Gamble Company	Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze
US5213568A (en)	1990-03-30	1993-05-25	Medtronic Inc.	Activity controlled electrotransport drug delivery device
WO1991015261A1 (en)	1990-03-30	1991-10-17	Medtronic, Inc.	Activity controlled electrotransport drug delivery device
PL168968B1 (en) *	1990-10-31	1996-05-31	Procter & Gamble	Method of manufacturing an antitussive drug
GB9103302D0 (en)	1991-02-16	1991-04-03	Smithkline Beecham Plc	Pharmaceutical formulations
WO1993007902A1 (en)	1991-10-16	1993-04-29	Richardson-Vicks, Inc.	Enhanced skin penetration system for improved topical delivery of drugs
EG20380A (en)	1991-10-16	1999-02-28	Richardson Vicks Inc	Enhanced skin penetration system for improved topical delivery of drugs
US5260066A (en)	1992-01-16	1993-11-09	Srchem Incorporated	Cryogel bandage containing therapeutic agent
US5756117A (en) *	1992-04-08	1998-05-26	International Medical Asscociates, Inc.	Multidose transdermal drug delivery system
WO1995005416A2 (en)	1993-08-19	1995-02-23	Cygnus Therapeutic Systems	Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity

1996
- 1996-04-23 SE SE9601528A patent/SE9601528D0/xx unknown
1997
- 1997-03-21 PT PT97915801T patent/PT904067E/pt unknown
- 1997-03-21 AU AU23132/97A patent/AU714942B2/en not_active Ceased
- 1997-03-21 WO PCT/SE1997/000484 patent/WO1997039742A1/en active IP Right Grant
- 1997-03-21 DE DE69731882T patent/DE69731882T2/de not_active Expired - Fee Related
- 1997-03-21 US US09/171,674 patent/US6335030B1/en not_active Expired - Lifetime
- 1997-03-21 NZ NZ332215A patent/NZ332215A/xx unknown
- 1997-03-21 EP EP97915801A patent/EP0904067B1/de not_active Expired - Lifetime
- 1997-03-21 JP JP9537974A patent/JP2000509037A/ja active Pending
- 1997-03-21 CA CA002251966A patent/CA2251966C/en not_active Expired - Fee Related
- 1997-03-21 AT AT97915801T patent/ATE284206T1/de not_active IP Right Cessation
- 1997-03-21 ES ES97915801T patent/ES2234012T3/es not_active Expired - Lifetime
- 1997-03-21 DK DK97915801T patent/DK0904067T3/da active
- 1997-04-22 ZA ZA9703444A patent/ZA973444B/xx unknown

Also Published As

Publication number	Publication date
PT904067E (pt)	2005-02-28
US6335030B1 (en)	2002-01-01
EP0904067A1 (de)	1999-03-31
JP2000509037A (ja)	2000-07-18
AU714942B2 (en)	2000-01-13
NZ332215A (en)	2000-09-29
CA2251966A1 (en)	1997-10-30
ES2234012T3 (es)	2005-06-16
ZA973444B (en)	1997-11-18
EP0904067B1 (de)	2004-12-08
CA2251966C (en)	2008-01-15
ATE284206T1 (de)	2004-12-15
AU2313297A (en)	1997-11-12
SE9601528D0 (sv)	1996-04-23
DE69731882T2 (de)	2005-12-15
DE69731882D1 (de)	2005-01-13
WO1997039742A1 (en)	1997-10-30

Publication	Publication Date	Title
DK0904067T3 (da)	2005-03-14	Transdermalt indgivet dextromethorpan som hostestillende middel
NO944249L (no)	1994-11-14	Transdermal administrering av oksybutynin
NZ508526A (en)	2004-12-24	Opioid formulations for treating pain
WO2001013909A3 (en)	2001-05-25	Compositions and methods for treating opiate intolerance
PT1239849E (pt)	2006-07-31	Formulacoes farmaceuticas que compreendem resveratrol e a sua utilizacao
GR3032523T3 (en)	2000-05-31	Therapeutic preparation for the transdermal administration of active substances
NO20022014L (no)	2002-06-20	En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
CA2341063A1 (en)	2000-03-09	Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
ATE321529T1 (de)	2006-04-15	Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
TR199801180T2 (xx)	1998-10-21	Aneljestik etkiye sahip yeni bile�ikler.
NO931766D0 (no)	1993-05-14	Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
AR039130A2 (es)	2005-02-09	Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
KR950703951A (ko)	1995-11-17	광학적으로 순수한 r-케토로락을 포함하는 조성물과 무통과 해열치료에 이를 사용하는 방법(antipyretic and analgesic methods and compositions containing optically pure r-ketorolac)
YU49026B (sh)	2003-07-07	UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
NO20006604L (no)	2001-02-28	Fremgangsmåter og transdermale sammensetninger for lindring av smerte
ATE202926T1 (de)	2001-07-15	Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
ATE238778T1 (de)	2003-05-15	Transdermales therapeutisches system zur abgabe von hormonen
DK0538302T3 (da)	1995-09-18	Reduktion eller forhindring af hudirritation forårsaget af lægemidler
ES2135342B1 (es)	2000-05-16	Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
SE9601527D0 (sv)	1996-04-23	Transdermally alministered acetylcysteine as mucolytic agent
MY126321A (en)	2006-09-29	Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
TR199801184T2 (xx)	1998-09-21	Analjezik tesirli yeni bile�ikler.
ATE280575T1 (de)	2004-11-15	Transdermales therapeutisches system zur anwendung von candesartan
EP0906757A3 (de)	2001-05-16	Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
DK408188D0 (da)	1988-07-21	Injicerbart middel til kontrolleret frigivelse af opioid-analgetika